Literature DB >> 18563892

Structure-activity relationships of 7-deaza-6-benzylthioinosine analogues as ligands of Toxoplasma gondii adenosine kinase.

Young Ah Kim1, Ashoke Sharon, Chung K Chu, Reem H Rais, Omar N Al Safarjalani, Fardos N M Naguib, Mahmoud H el Kouni.   

Abstract

Several 7-deaza-6-benzylthioinosine analogues with varied substituents on aromatic ring were synthesized and evaluated against Toxoplasma gondii adenosine kinase (EC.2.7.1.20). Structure-activity relationships indicated that the nitrogen atom at the 7-position does not appear to be a critical structural requirement. Molecular modeling reveals that the 7-deazapurine motif provided flexibility to the 6-benzylthio group as a result of the absence of H-bonding between N7 and Thr140. This flexibility allowed better fitting of the 6-benzylthio group into the hydrophobic pocket of the enzyme at the 6-position. In general, single substitutions at the para or meta position enhanced binding. On the other hand, single substitutions at the ortho position led to the loss of binding affinity. The most potent compounds, 7-deaza- p-cyano-6-benzylthioinosine (IC 50 = 5.3 microM) and 7-deaza- p-methoxy-6-benzylthioinosine (IC 50 = 4.6 microM), were evaluated in cell culture to delineate their selective toxicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18563892     DOI: 10.1021/jm800201s

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase: biological activities and selective toxicities.

Authors:  Omar N Al Safarjalani; Reem H Rais; Young Ah Kim; Chung K Chu; Fardos N M Naguib; Mahmoud H El Kouni
Journal:  Biochem Pharmacol       Date:  2010-06-10       Impact factor: 5.858

2.  Exploring natural product chemistry and biology with multicomponent reactions. 5. Discovery of a novel tubulin-targeting scaffold derived from the rigidin family of marine alkaloids.

Authors:  Liliya V Frolova; Igor V Magedov; Anntherese E Romero; Menuka Karki; Isaiah Otero; Kathryn Hayden; Nikolai M Evdokimov; Laetitia Moreno Y Banuls; Shiva K Rastogi; W Ross Smith; Shi-Long Lu; Robert Kiss; Charles B Shuster; Ernest Hamel; Tania Betancourt; Snezna Rogelj; Alexander Kornienko
Journal:  J Med Chem       Date:  2013-08-23       Impact factor: 7.446

3.  Kinetic mechanism of Toxoplasma gondii adenosine kinase and the highly efficient utilization of adenosine.

Authors:  Fardos N M Naguib; Reem H Rais; Omar N Al Safarjalani; Mahmoud H el Kouni
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2015-06-23       Impact factor: 2.231

Review 4.  Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.

Authors:  Madalyn M McFarland; Sydney J Zach; Xiaofang Wang; Lakshmi-Prasad Potluri; Andrew J Neville; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

Review 5.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

6.  7-Deaza-6-benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: activities and selective toxicities.

Authors:  Omar N Al Safarjalani; Reem H Rais; Young Ah Kim; Chung K Chu; Fardos N M Naguib; Mahmoud H el Kouni
Journal:  Biochem Pharmacol       Date:  2008-08-07       Impact factor: 5.858

7.  Sugar modified pyrimido[4,5-b]indole nucleosides: synthesis and antiviral activity.

Authors:  Juraj Konč; Michal Tichý; Radek Pohl; Jan Hodek; Petr Džubák; Marián Hajdúch; Michal Hocek
Journal:  Medchemcomm       Date:  2017-08-25       Impact factor: 3.597

8.  A Toxoplasma gondii Oxopurine Transporter Binds Nucleobases and Nucleosides Using Different Binding Modes.

Authors:  Gustavo D Campagnaro; Hamza A A Elati; Sofia Balaska; Maria Esther Martin Abril; Manal J Natto; Fabian Hulpia; Kelly Lee; Lilach Sheiner; Serge Van Calenbergh; Harry P de Koning
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.